Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Axsome Therapeutics (AXSM) Goodwill & Intangibles: 2022-2024

Historic Goodwill & Intangibles for Axsome Therapeutics (AXSM) over the last 3 years, with Dec 2024 value amounting to $75.8 million.

  • Axsome Therapeutics' Goodwill & Intangibles changed negligibly% to $75.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $75.8 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $75.8 million for FY2024, which is negligibly% changed negligibly from last year.
  • As of FY2024, Axsome Therapeutics' Goodwill & Intangibles stood at $75.8 million, which was down 0.00% from $75.8 million recorded in FY2023.
  • Axsome Therapeutics' Goodwill & Intangibles' 5-year high stood at $75.8 million during FY2023, with a 5-year trough of $74.1 million in FY2022.
  • Over the past 3 years, Axsome Therapeutics' median Goodwill & Intangibles value was $75.8 million (recorded in 2024), while the average stood at $75.3 million.
  • Data for Axsome Therapeutics' Goodwill & Intangibles shows a peak YoY increased of 2.34% (in 2023) over the last 5 years.
  • Over the past 3 years, Axsome Therapeutics' Goodwill & Intangibles (Yearly) stood at $74.1 million in 2022, then climbed by 2.34% to $75.8 million in 2023, then remained steady at $75.8 million in 2024.